Table 2.
Prevalence of anogenital HPV types (at any anogenital site and stratified by site) and oral HPV types.
| Any Anogenital Sitea | Analb | Perianalc | Penile/Scrotald | Oral | |
|---|---|---|---|---|---|
|
(n = 141) |
(n = 137) |
(n = 136) |
(n = 133) |
(n = 139) |
|
| HPV type | N (%) | N (%) | N (%) | N (%) | N (%) |
| Any HPV typee | 134 (95) | 128 (93) | 104 (76) | 53 (40) | 9 (6) |
| 2-valent vaccine types (16, 18) | 35 (25) | 34 (25) | 15 (11) | 2 (2) | 0 (0) |
| 4-valent vaccine types (6, 11, 16, 18) | 81 (57) | 73 (53) | 46 (34) | 14 (11) | 0 (0) |
| 9-valent vaccine types (6, 11, 16, 18, 31, 33, 45, 52, 58) | 99 (70) | 93 (68) | 59 (43) | 16 (12) | 0 (0) |
| High-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82) | 98 (70) | 95 (69) | 51 (38) | 11 (8) | 3 (2) |
| HPV6f | 55 (39) | 49 (36) | 26 (19) | 8 (6) | 0 (0) |
| HPV11f | 24 (17) | 17 (12) | 15 (11) | 6 (5) | 0 (0) |
| HPV16f | 26 (18) | 25 (18) | 9 (7) | 2 (2) | 0 (0) |
| HPV18f | 15 (11) | 14 (10) | 6 (4) | 0 (0) | 0 (0) |
| HPV31g | 12 (9) | 12 (9) | 2 (1) | 0 (0) | 0 (0) |
| HPV33g | 12 (9) | 12 (9) | 5 (4) | 0 (0) | 0 (0) |
| HPV35 | 19 (13) | 18 (13) | 5 (4) | 0 (0) | 2 (1) |
| HPV39 | 11 (8) | 10 (7) | 3 (2) | 1 (1) | 1 (1) |
| HPV45g | 14 (10) | 13 (9) | 6 (4) | 0 (0) | 0 (0) |
| HPV51 | 21 (15) | 19 (14) | 8 (6) | 4 (3) | 0 (0) |
| HPV52g | 14 (10) | 13 (9) | 7 (5) | 1 (1) | 0 (0) |
| HPV56 | 8 (6) | 7 (5) | 3 (2) | 1 (1) | 0 (0) |
| HPV58g | 22 (16) | 19 (14) | 7 (5) | 1 (1) | 0 (0) |
| HPV59 | 13 (9) | 13 (9) | 7 (5) | 1 (1) | 0 (0) |
| HPV68 | 13 (9) | 12 (9) | 4 (3) | 2 (2) | 0 (0) |
| HPV73 | 6 (4) | 6 (4) | 1 (1) | 1 (1) | 0 (0) |
| HPV82 | 15 (11) | 9 (7) | 5 (4) | 3 (2) | 0 (0) |
| HPV26/69h | 6 (4) | 6 (4) | 1 (1) | 0 (0) | 0 (0) |
| HPV30 | 8 (6) | 7 (5) | 3 (2) | 0 (0) | 0 (0) |
| HPV32/42 | 13 (9) | 11 (8) | 4 (3) | 1 (1) | 3 (2) |
| HPV34 | 4 (3) | 3 (2) | 0 (0) | 1 (1) | 0 (0) |
| HPV53 | 20 (14) | 19 (14) | 7 (5) | 1 (1) | 0 (0) |
| HPV54 | 10 (7) | 10 (7) | 7 (5) | 1 (1) | 0 (0) |
| HPV57/2/27 | 1 (1) | 0 (0) | 0 (0) | 1 (1) | 0 (0) |
| HPV61 | 12 (9) | 12 (9) | 7 (5) | 0 (0) | 0 (0) |
| HPV62 | 19 (13) | 17 (12) | 11 (8) | 4 (3) | 0 (0) |
| HPV66 | 4 (3) | 2 (1) | 2 (1) | 0 (0) | 0 (0) |
| HPV67 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| HPV70 | 7 (5) | 6 (4) | 3 (2) | 0 (0) | 0 (0) |
| HPV71 | 2 (1) | 1 (1) | 1 (1) | 0 (0) | 1 (1) |
| HPV72 | 8 (6) | 6 (4) | 1 (1) | 1 (1) | 1 (1) |
| HPV81 | 12 (9) | 11 (8) | 9 (7) | 0 (0) | 0 (0) |
| HPV83 | 14 (10) | 11 (8) | 7 (5) | 2 (2) | 1 (1) |
| HPV84 | 21 (15) | 17 (12) | 12 (9) | 3 (2) | 0 (0) |
| HPV85 | 3 (2) | 3 (2) | 0 (0) | 0 (0) | 0 (0) |
| HPV86/87 | 14 (10) | 10 (7) | 10 (7) | 1 (1) | 0 (0) |
| HPV90/106 | 18 (13) | 14 (10) | 10 (7) | 1 (1) | 0 (0) |
| HPV97 | 1 (1) | 1 (1) | 1 (1) | 0 (0) | 0 (0) |
| HPV102/89 | 6 (4) | 3 (2) | 3 (2) | 1 (1) | 0 (0) |
Any anogenital site includes participants with samples from 1 to 3 anogenital sites.
Anal only, anal + perianal, anal + penile/scrotal.
Perianal only, perianal + anal, perianal + penile/scrotal.
Penile/scrotal only, penile/scrotal + anal, penile/scrotal + perianal.
Positive for ≥1 HPV type.
Indicates types in the quadrivalent vaccine and nine-valent vaccine.
Indicates types only in the nine-valent vaccine.
We tested for 33 types individually (6, 11, 16, 18, 30, 31, 33, 34, 35, 39, 45, 51, 52, 53, 54, 56, 58, 59, 61, 62, 66, 67, 68, 70, 71, 72, 73, 81, 82, 83, 84, 85, and 97), and 8 mixtures of 2–8 types (32/42, 26/69, 57/2/27, 86/87, 90/106, 102/89, Mix1 containing 7, 13, 40, 43, 44, 55, 74, and 91, and Mix2 containing 3, 10, 28, 29, 77, 78, and 94).